Skip to main content

Share story

Products

Anthropic Appoints Legal Tech Founder Robert Mahari as Head of Claude for Legal

An image related to Anthropic Appoints Legal Tech Founder Robert Mahari as Head of Claude for Legal Image: Primary
Anthropic appointed Robert Mahari as head of Claude for Legal, the company said Thursday. Mahari, founder of custom-build legal software developer Akiva AI, announced the appointment in a LinkedIn post. Anthropic has not yet responded to Law.com's request for comment on the matter. Mahari said he plans to inform legal professionals about Anthropic's AI technology in the new role. His appointment follows Anthropic's steady launch of legal tech capabilities and integrations within its Claude large language model this year. Other AI developers and platforms have also started leaning into legal tech as Anthropic bolsters its Claude legal technology and team.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from law.com and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

Security
Security

Gyazo breach exposed metadata for 490 million images

A breach at screenshot-sharing service Gyazo exposed nearly 24 million customer records and an additional 490 million image-metadata records, Infosecurity Magazine reported. Attackers exploited an upload-server vulnerability, gain...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...